A Commentary on the NIH Consensus Development Statement ‘Genetic Testing for Cystic Fibrosis’

Publisher： Karger

E-ISSN： 1662-8063|1|1|53-56

ISSN： 1662-4246

Source： Public Health Genomics, Vol.1, Iss.1, 1998-05, pp. : 53-56

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anxiety Related to Genetic Testing for Alpha-1 Antitrypsin Deficiency and Cystic Fibrosis in COPD and/or Bronchiectasis Patients

By  

Public Health Genomics, Vol. 11, Iss. 3, 2008-03 ,pp. : 135-140

Karger

Access to resources Recommend Favorite

Uptake and Impact of Carrier Testing for Cystic Fibrosis

By  

Public Health Genomics, Vol. 1, Iss. 1, 1998-05 ,pp. : 23-35

Karger

Access to resources Recommend Favorite

Genetic pathways explored for role in cystic fibrosis

By  

American Journal Of Medical Genetics Part A, Vol. 167, Iss. 6, 2015-06 ,pp. : ix-x

John Wiley & Sons Inc

Access to resources Recommend Favorite

Consensus Statement on Terminology and Management: Disorders of Sex Development

By  

Sexual Development, Vol. 2, Iss. 4-5, 2008-11 ,pp. : 172-180

Karger

Access to resources Recommend Favorite

Population-Based Genetic Screening for Cystic Fibrosis: Attitudes and Outcomes

By  

Public Health Genomics, Vol. 13, Iss. 7-8, 2010-01 ,pp. : 449-456

Karger

Access to resources Recommend Favorite